Today on our podcast show, Michael, who is one of Australia's most distinguished and multi-award-winning researchers, discusses the latest breakthroughs and treatments for Alzheimer’s dementia.

Professor Michael Valenzuela is co-founder and CEO of Skin2Neuron (S2N), a creative biotech company for the treatment and prevention of Alzheimer’s dementia.

S2N’s regenerative medicine technology is based on a discovery by Michael and his team at the University of Sydney in 2019. They found that there was a remarkable degree of shared biology between stem cells in the brain and stem cells in skin.